Does RISANKIZUMAB Cause Dermatitis exfoliative generalised? 11 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Dermatitis exfoliative generalised have been filed in association with RISANKIZUMAB (Skyrizi). This represents 0.4% of all adverse event reports for RISANKIZUMAB.
11
Reports of Dermatitis exfoliative generalised with RISANKIZUMAB
0.4%
of all RISANKIZUMAB reports
0
Deaths
0
Hospitalizations
How Dangerous Is Dermatitis exfoliative generalised From RISANKIZUMAB?
Of the 11 reports.
Is Dermatitis exfoliative generalised Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISANKIZUMAB. However, 11 reports have been filed with the FAERS database.
What Other Side Effects Does RISANKIZUMAB Cause?
Product storage error (396)
Drug ineffective (206)
Psoriasis (138)
Crohn's disease (103)
Arthralgia (100)
Off label use (100)
Product temperature excursion issue (88)
Diarrhoea (72)
Fatigue (70)
Rash (64)
What Other Drugs Cause Dermatitis exfoliative generalised?
ALLOPURINOL (192)
DUPILUMAB (162)
METHOTREXATE (151)
SULFAMETHOXAZOLE\TRIMETHOPRIM (140)
AMOXICILLIN (122)
ADALIMUMAB (113)
PANTOPRAZOLE (105)
SECUKINUMAB (96)
VANCOMYCIN (92)
AMLODIPINE (91)
Which RISANKIZUMAB Alternatives Have Lower Dermatitis exfoliative generalised Risk?
RISANKIZUMAB vs RISANKIZUMAB-RZAA
RISANKIZUMAB vs RISDIPLAM
RISANKIZUMAB vs RISEDRONATE
RISANKIZUMAB vs RISEDRONIC ACID
RISANKIZUMAB vs RISPERDAL